Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent
Prescription品牌名称： PNV-DHA
About This Medication
DESCRIPTION PNV-DHA + Docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with DHA. Each softgel is red in color and imprinted with “323” on one side. † Daily Value (DV) not established. SUPPLEMENT FACTS Serving Size: 1 softgel Amount Per Serving % Daily Value Vitamin C (as ascorbic acid, USP) 28 mg 47% Calcium (tribasic calcium phosphate, NF) 160 mg 16% Iron (as ferrous fumarate, USP) 27 mg 150% Vitamin D 3 (as cholecalciferol, USP) 400 IU 100% Vitamin E (as d-alpha-tocopherol acetate, USP) 30 IU 100% Vitamin B 6 (as pyridoxine HCl, USP) 25 mg 1250% Folic Acid, USP 1.25 mg 313% DHA (docosahexaenoic acid) 300 mg † Docusate sodium, USP 55 mg † OTHER INGREDIENTS Bovine Gelatin, Glycerin, Soybean Oil, Soy Lecithin, Purified Water, Yellow Beeswax, FD&C Red # 40, Titanium Dioxide, Orange Cream Flavor, Ethyl Vanillin, FD&C Yellow # 6, and FD&C Blue #1. Contains soy. INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
活性成分
| 成分 | 规格 |
|---|---|
| .Alpha.-Tocopherol Acetate, Dl- | - |
| Ascorbic Acid | - |
| Calcium | - |
| Cholecalciferol | - |
| Doconexent | - |
| Ferrous Fumarate | - |
| Folic Acid | - |
| Pyridoxine | - |
适应证与用法
用法用量
Side Effects Overview
警告与注意事项
WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
禁忌证
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Frequently Asked Questions
INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
DOSAGE AND ADMINISTRATION Usual adult dose is one (1) softgel daily or as directed by a physician. KEEP OUT OF REACH OF CHILDREN.
WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent drug label (National Library of Medicine)
- • openFDA — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent label data (U.S. Food & Drug Administration)
- • NDC Directory — Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent (FDA National Drug Code)
医疗免责声明
本页面信息仅供教育参考之用，不得用于替代专业医疗建议、诊断或治疗。
如有任何关于病症或药物的疑问，请务必咨询您的医生或其他具有资质的医疗保健提供者。
数据来源： DailyMed (NLM), openFDA, MFDS